Association of British Clinical Diabetologists and The Renal Association. Clinical practice guidelines for management of hyperglycaemia in adults with diabetic kidney disease. 2021. (accessed 12 October 2021)

6. Glycemic Targets: Standards of Medical Care in Diabetes-2019. Diabetes Care. 2019; 42:S61-S70

Baxter M, Hudson R, Mahon J. Estimating the impact of better management of glycaemic control in adults with Type 1 and Type 2 diabetes on the number of clinical complications and the associated financial benefit. Diabet Med. 2016; 33:1575-1581

British Geriatrics Society. Diabetes. 2018. (accessed 12 October 2021)

British In Vitro Diagnostics Association Changes to the ISO 15197: 2013 Standard – Urgent Action Required. 2016. (accessed 12 October 2021)

Davies MJ, Gagliardino JJ, Gray LJ, Khunti K, Mohan V, Hughes R. Real-world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review. Diabet Med. 2013; 30:(5)512-24

Diabetes Research and Wellness Foundation. New report reveals the NHS bill for treating diabetes has doubled over last decade. 2019. (accessed 12 October 2021)

Diabetes UK. Diabetes: the basics. 2021b. (accessed 27 Oct 2021)

Diabetes UK. Diabetes statistics. 2021b. (accessed 9 October 2021)

Diabetes UK. Diabetes stats and facts. 2015. (accessed 12 October 2021)

GOV.UK. Diabetes mellitus: assessing fitness to drive. 2021. (accessed 12 October 2021)

Hex N, Bartlett C, Wright D, Taylor M, Varley D. Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs. Diabet Med. 2012; 29:(7)855-62

Miller KM, Beck RW, Bergenstal RM Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013; 36:(7)2009-14

Diabetes Times. Up to a third of people with type 2 diabetes not taking prescriptions properly says study. 2019. (accessed 12 October 2021)

National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management NICE guideline [NG17]. 2015. (Accessed 27 Oct 2021)

National Institute for Health and Care Excellence. Type 2 diabetes: prevention in people at high risk. 2017. (accessed 12 October 2021)

National Institute for Health and Care Excellence NICE impact diabetes. 2018. (accessed 12 October 2021)

National Institute for Health and Care Excellence. Type 2 diabetes in adults: management (NG28). 2020. (accessed 12 October 2021)

National Institute for Health and Care Excellence. Diabetes in pregnancy: management from preconception to the postnatal period (NG3). 2020. (accessed 12 October 2021)

National Institute for Health and Care Excellence. Type 1 diabetes in adults: diagnosis and management (NG17). 2021. (accessed 12 October 2021)

NHS. What is type 2 diabetes?. 2020. (accessed 27 Oct 2021)

NHS. NHS Diabetes Prevention Programme. 2021. (accessed 27 Oct 2021)

NHS England. Record high two million people at risk of Type 2 Diabetes. 2020. (accessed: 9 October 2021)

Telo GH, de Souza MS, Andrade TS., Schann BDA. Comparison between adherence assessments and blood glucose monitoring measures to predict glycaemic control in adults with type 1 diabetes: a cross-sectional study. Diabetology and Metabolic Syndrome. 2016; 8:(54)

Thomas NJ, Jones SE, Weedon MN, Shields BM, Oram RA, Hattersley AT. Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank. Lancet Diabetes Endocrinol. 2018; 6:(2)122-129

Yi WM, Van Wieren Jones EM, Hansen BK, Vora J. The Impact of Self-Monitoring Blood Glucose Adherence On Glycemic Goal Attainment in an Indigent Population, With Pharmacy Assistance. P T. 2019; 44:(9)554-559

Monitoring of blood glucose levels, ketones and insulin bolus advice using 4SURE products and app-based technology

13 January 2022
Volume 31 · Issue 1


With more people being diagnosed with diabetes and requiring insulin therapy as they live longer, an increasing number of individuals are needing access to blood and ketone monitoring that is simple to use and provides accurate results. Having access to a bolus advisor is equally important in order for people with diabetes to calculate accurate insulin doses based on the foods that they are eating. The use of app-based technology for healthcare purposes has increased over recent years and now includes the Diabetes:M application that can be used in conjunction with the 4SURE smart meters with no additional cost to the individual.

Diabetes is a condition where a person's blood glucose levels are too high. It can occur when not enough insulin is produced or the insulin that is produced is not utilised effectively (ie type 2 diabetes) or when the body cannot produce any insulin at all (ie type 1 diabetes) (Diabetes UK, 2021a). There are currently 4.7 million people in the UK who have been diagnosed with diabetes and this figure is predicted to rise to 5.5 million by 2030 (Diabetes UK, 2021b). Approximately 90% of these individuals have type 2 diabetes, 8% have type 1 diabetes and 2% have rarer types of diabetes (such as monogenic diabetes) (Diabetes UK, 2021b). Type 1 diabetes is the most common form of diabetes found in children. More recent research, however, has shown that 42% of new diagnosis of type 1 diabetes occurs after age 30 years (Thomas et al, 2018).

Register now to continue reading

Thank you for visiting British Journal of Nursing and reading some of our peer-reviewed resources for nurses. To read more, please register today. You’ll enjoy the following great benefits:

What's included

  • Limited access to clinical or professional articles

  • Unlimited access to the latest news, blogs and video content